Cyclic nucleotides can relax smooth muscle without a change in [Ca 2؉ ]i, a phenomenon termed Ca 2؉ desensitization, contributing to vasodilation, gastrointestinal motility, and airway resistance. The physiological importance of telokin, a 17-kDa smooth musclespecific protein and target for cyclic nucleotide-induced Ca 2؉ desensitization, was determined in telokin null mice bred to a congenic background. Telokin null ileal smooth muscle homogenates compared to wild type exhibited an Ϸ30% decrease in myosin light-chain phosphatase (MLCP) activity, which was reflected in a significant leftward shift (up to 2-fold at pCa 6.3) of the Ca 2؉ force relationship accompanied by an increase in myosin light-chain phosphorylation. No difference in the Ca 2؉ force relationship occurred in telokin WT and knockout (KO) aortas, presumably reflecting the normally Ϸ5-fold lower telokin content in aorta vs. ileum smooth muscle. Ca 2؉ desensitization of contractile force by 8-Br-cGMP was attenuated by 50% in telokin KO intestinal smooth muscle. The rate of force relaxation reflecting MLCP activity, in the presence of 50 M 8-Br-cGMP, was also significantly slowed in telokin KO vs. WT ileum and was rescued by recombinant telokin. Normal thick filaments in telokin KO smooth muscles indicate that telokin is not required for filament formation or stability. Results indicate that a primary role of telokin is to modulate force through increasing MLCP activity and that this effect is further potentiated through phosphorylation by cGMP in telokin-rich smooth tissues. S mooth muscle (SM) myosin II ATPase activity and associated contraction is activated by actin only when Ser-19 of the myosin regulatory light chain (RLC 20 ) is phosphorylated. The extent of RLC 20 phosphorylation is a reflection of the balance between Ca 2ϩ calmodulin-dependent myosin light-chain kinase (MLCK) and myosin light-chain phosphatase (MLCP) activities. Although the major mechanism for initiating contraction is the rise in [Ca 2ϩ ] i , force can be further increased or decreased through signaling pathways that modulate MLCK and͞or MLCP activities giving rise to processes termed Ca 2ϩ sensitization or -desensitization (reviewed in ref. 1). Ca 2ϩ sensitization due to inhibition of MLCP activity is mediated by an agonist G protein-coupled, Ca 2ϩ -independent process that activates RhoA͞Rho-kinase, phosphorylates the myosin regulatory subunit of MLCP (MYPT1), and leads to increased force (1). On the other hand, cyclic nucleotideactivated kinases, in addition to decreasing cytosolic Ca 2ϩ , make a significant contribution to dephosphorylation of RLC 20 and relaxation through Ca 2ϩ -desensitization processes (2-5) and can reverse G protein-coupled Ca 2ϩ sensitization (2, 3). Interaction between the leucine zipper motifs of protein kinase G and MYPT1 leads to direct stimulation of MLCP (6). A role for this interaction in Ca 2ϩ desensitization is supported by the observation that chicken gizzard MYPT1 lacking the leucine zipper motifs is resistant to 8-BrcGMP-induced depho...